June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
To evaluate the efficacy of corneal collagen crosslinking in fungal corneal ulcers
Author Affiliations & Notes
  • shah nawaz
    Opthalmology, R.P.Centre, AIIMS, New Delhi, India
  • Prafulla Maharana
    Opthalmology, R.P.Centre, AIIMS, New Delhi, India
  • Namrata Sharma
    Opthalmology, R.P.Centre, AIIMS, New Delhi, India
  • Rasik Vajpayee
    Opthalmology, R.P.Centre, AIIMS, New Delhi, India
  • Footnotes
    Commercial Relationships shah nawaz, None; Prafulla Maharana, None; Namrata Sharma, None; Rasik Vajpayee, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 4304. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      shah nawaz, Prafulla Maharana, Namrata Sharma, Rasik Vajpayee; To evaluate the efficacy of corneal collagen crosslinking in fungal corneal ulcers. Invest. Ophthalmol. Vis. Sci. 2013;54(15):4304.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To study the efficacy of corneal collagen crosslinking(CXL) in treatment of moderate fungal corneal ulcers.

Methods: Thirty-seven cases of micro-biologically proven moderate fungal corneal ulcers were divided in two groups.Group 1 received medical therapy with CXL on day 1 of presentation. Group 2 received medical therapy alone.Medical therapy included topical Natamycin 5% drops .In cases of deep and large ulcers additional systemic therapy was given. CXL was done using riboflavin 1% with UVA 370nm. The parameters analyzed included healing time, final BCVA and perforation rate.

Results: Mean age in group 1 was 43.5 ±17.01 years and 39.6±19.7 years in group 2, statistically insignificant(p value 0.604). Average ulcer size in-group 1 was 25.79±16.7 mm2 and 25.4±12.4 mm2 in-group 2, statistically insignificant (p value 0.915). BCVA at presentation in group 1 was 1.48 ±0.46 Log MAR and 1.56±0.435 Log MAR in group 2, statistically insignificant (p value 0.6618). 13 out of 15 cases (86.6%) in group 1 and 11/12 (91.67%) cases in group 2 healed (p value 0.56), statistically not significant .The average healing time of ulcer in group 1 was 43.08 days ±26.6 and 39.2± 19.7 days in group 2, statistically insignificant (p value 0.673). Final BCVA in group 1 was 1.3522 ±0.46 Log MAR and 1.26± 0.43 Log MAR in group 2, statistically insignificant (p value 0.434).

Conclusions: CXL offers no advantage as an adjunctive treatment in the treatment of moderate fungal corneal ulcers.

Keywords: 479 cornea: clinical science  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×